FTC asks court to hold Martin Shkreli in contempt for launching new drug company | Engadget

a judge to put the ban on hold, arguing that the public could benefit from his future contributions to the industry. Shkreli challenged the ban while he was serving time in federal prison after receiving a seven-year sentence in 2017 for defrauding investors. He was released from prison in May.

The FTC said it started asking Shkreli for a compliance report and access to relevant records, as well as asking him to sit for an interview regarding Druglike, in October 2022. However, the company co-founder kept on disregarding its"repeated requests." The agency also said that Shkreli any amount of his $64.6 million fine. It's now asking the court to order Shkreli to comply with its information requests within 21 days of its decision. You can disable notifications at any time in your settings menu.

This guy...

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

FTC calls on federal court to hold 'pharma bro' Martin Shkreli in contempt | CNN BusinessThe Federal Trade Commission on Friday called for a federal court to hold 'Pharma Bro' Martin Shkreli in contempt after Shkreli allegedly flouted a recent FTC investigation into his business dealings and failed to make a $64.6 million payment he owed for his prior wrongdoings. The King of slappable faces. Seeking to retain his 'most hated' title? Can't we just use a baseball bat? It would be a lot faster
출처: CNN - 🏆 4. / 95 더 많은 것을 읽으십시오 »

FTC Alleges Martin 'Pharma Bro' Shkreli Is Trying to Break Back Into Pharma IndustryA federal judge previously barred the former CEO of Vyera Pharmaceutical from in any way working with or in the pharma industry again. Once a scumbag capitalist always a scumbag capitalist.
출처: Gizmodo - 🏆 556. / 51 더 많은 것을 읽으십시오 »